The key to the success of tuberculosis (TB) as a pathogen is its ability to evade the immune response and so, in seeking out improved and effective new treatments, it is imperative to understand what genes and virulence factors help TB survive within a host cell. In this video interview, Dr. Kyle Rohde, associate professor at the University of Central Florida, discusses his lab's in vitro studies of TB and how they hope to address this global medical crisis. Rohde goes on to explain how the use of NuAire's biosafety cabinets provides the sterility and containment required to conduct safe infection experiments of this mycobacterium.